Healthcare provider profile · identity verified

Melissa S Dodrill, M.D.

Family Practice · WEST MILFORD, WV · NPI 1871887349

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Pantoprazole Sodium	Pantoprazole Sodium	282	78
Atorvastatin Calcium	Atorvastatin Calcium	245	68
Levothyroxine Sodium	Levothyroxine Sodium	211	46
Gabapentin	Gabapentin	209	49
Omeprazole	Omeprazole	201	54
Lisinopril	Lisinopril	193	56
Losartan Potassium	Losartan Potassium	192	42
Albuterol Sulfate Hfa	Albuterol Sulfate	185	50
Montelukast Sodium	Montelukast Sodium	164	42
Rosuvastatin Calcium	Rosuvastatin Calcium	163	48
Metoprolol Succinate	Metoprolol Succinate	154	46
Famotidine	Famotidine	147	31
Fluticasone Propionate	Fluticasone Propionate	143	42
Duloxetine Hcl	Duloxetine Hcl	138	29
Amlodipine Besylate	Amlodipine Besylate	136	46
Sertraline Hcl	Sertraline Hcl	126	32
Tizanidine Hcl	Tizanidine Hcl	111	28
Hydrochlorothiazide	Hydrochlorothiazide	107	29
Clopidogrel	Clopidogrel Bisulfate	106	25
Metformin Hcl Er	Metformin Hcl	106	27
Pravastatin Sodium	Pravastatin Sodium	100	28
Furosemide	Furosemide	98	35
Metformin Hcl	Metformin Hcl	97	28
Jardiance	Empagliflozin	96	22
Trulicity	Dulaglutide	93	14
Escitalopram Oxalate	Escitalopram Oxalate	86	22
Ozempic	Semaglutide	84	14
Trazodone Hcl	Trazodone Hcl	77	19
Buspirone Hcl	Buspirone Hcl	76	27
Tamsulosin Hcl	Tamsulosin Hcl	73	21
Metoprolol Tartrate	Metoprolol Tartrate	69	20
Meloxicam	Meloxicam	68	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	65	14
Ibuprofen	Ibuprofen	62	16
Ropinirole Hcl	Ropinirole Hcl	56	15
Allopurinol	Allopurinol	53	16
Meclizine Hcl	Meclizine Hcl	53	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	51	15
Hydroxyzine Hcl	Hydroxyzine Hcl	49	11
Mounjaro	Tirzepatide	49	suppressed
Glipizide Er	Glipizide	48	suppressed
Prednisone	Prednisone	48	29
Pregabalin	Pregabalin	47	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	46	15
Incruse Ellipta	Umeclidinium Bromide	44	suppressed
Potassium Chloride	Potassium Chloride	44	16
Glipizide	Glipizide	43	11
Diclofenac Sodium	Diclofenac Sodium	42	11
Topiramate	Topiramate	41	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	40	11
Eliquis	Apixaban	39	suppressed
Simvastatin	Simvastatin	38	11
Advair Hfa	Fluticasone Propion/Salmeterol	36	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	36	suppressed
Valacyclovir	Valacyclovir Hcl	36	suppressed
Ezetimibe	Ezetimibe	35	suppressed
Mirtazapine	Mirtazapine	35	11
Finasteride	Finasteride	34	suppressed
Symbicort	Budesonide/Formoterol Fumarate	34	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Cephalexin	Cephalexin	31	13
Azelastine Hcl	Azelastine Hcl	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	30	suppressed
Ondansetron Odt	Ondansetron	30	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	20
Farxiga	Dapagliflozin Propanediol	29	suppressed
Lidocaine	Lidocaine	29	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	27	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	27	suppressed
Lovastatin	Lovastatin	26	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Methocarbamol	Methocarbamol	24	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Valsartan	Valsartan	24	suppressed
Naproxen	Naproxen	23	suppressed
Nystatin	Nystatin	23	13
Doxycycline Hyclate	Doxycycline Hyclate	22	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Spiriva Respimat	Tiotropium Bromide	22	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Carvedilol	Carvedilol	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	18	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Atenolol	Atenolol	17	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Fluconazole	Fluconazole	17	16
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Tramadol Hcl	Tramadol Hcl	15	suppressed
Tresiba Flextouch U-100	Insulin Degludec	15	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Levofloxacin	Levofloxacin	14	12
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Diazepam	Diazepam	13	suppressed
Spiriva Handihaler	Tiotropium Bromide	13	suppressed
Bumetanide	Bumetanide	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Celecoxib	Celecoxib	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Linzess	Linaclotide	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Novolog Flexpen	Insulin Aspart	12	suppressed
Ramipril	Ramipril	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Ibu	Ibuprofen	11	suppressed
Methylprednisolone	Methylprednisolone	11	11
Misoprostol	Misoprostol	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Spironolactone	Spironolactone	11	suppressed
Telmisartan	Telmisartan	11	suppressed
Tradjenta	Linagliptin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error